[DRESS syndrome to sulfasalzine].
We report a case of drug hypersensibility syndrome (DRESS syndrome) developed one month after initiation of a treatment by sulfasalazine. Due to the severity of the cytolytic hepatic damages as observed in this case, we emphasize the importance of suggesting this diagnosis in any patient developing a cutaneous rash and an alteration of the general health status after initiation of a new treatment. The hematologic alterations which represent a key feature for the diagnosis may rash. develop only a few days after the cutaneous rash.
Bourguignon
R
R
Service de Dermatologie, CHR Huy, Belgique.
Piérrard-Franchimont
C
C
Paquet
P
P
Piérard
G E
GE
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D012460:Sulfasalazine / Q000009:adverse effects*; D013577:Syndrome
D018501:Antirheumatic Agents; D012460:Sulfasalazine